Traws Pharma, Inc. Expected to Earn Q1 2024 Earnings of ($0.24) Per Share (NASDAQ:TRAW)
The Cerbat Gem - 2024-04-10T01:24:42.000Z

Traws Pharma, Inc. (NASDAQ:TRAW – Free Report) – Investment analysts at HC Wainwright issued their Q1 2024 earnings per share estimates for shares of Traws Pharma in a note issued to investors on Wednesday, April 3rd. HC Wainwright analyst J. Pantginis anticipates that the company will post earnings of ($0.24) per share for the quarter. […]

In related news

Sage Therapeutics, Inc. (NASDAQ:SAGE) to Post Q1 2024 Earnings of ($1.64) Per Share, Leerink Partnrs Forecasts
Sage Therapeutics, Inc. (NASDAQ:SAGE – Free Report) – Analysts at Leerink Partnrs increased their Q1 2024 earnings estimates for shares of Sage Therapeutics in a research report issued on Tuesday, April 9th. Leerink Partnrs analyst M. Goodman now expects that the biopharmaceutical company will earn ($1.64) per share for the quarter, up from their previous […]
- Related Articles
- In News
- From The Cerbat Gem
- 2024-04-14T01:22:43.000Z
Stoke Therapeutics, Inc. (NASDAQ:STOK) to Post Q2 2024 Earnings of ($0.43) Per Share, Leerink Partnrs Forecasts
Stoke Therapeutics, Inc. (NASDAQ:STOK – Free Report) – Analysts at Leerink Partnrs issued their Q2 2024 earnings per share (EPS) estimates for Stoke Therapeutics in a research note issued to investors on Tuesday, April 9th. Leerink Partnrs analyst R. Li forecasts that the company will post earnings per share of ($0.43) for the quarter. The […]
- Related Articles
- In News
- From The Cerbat Gem
- 2024-04-14T01:16:41.000Z
Ovintiv Inc. to Post Q1 2024 Earnings of $1.32 Per Share, Capital One Financial Forecasts (NYSE:OVV)
Ovintiv Inc. (NYSE:OVV – Free Report) – Equities researchers at Capital One Financial lifted their Q1 2024 EPS estimates for Ovintiv in a report released on Wednesday, April 3rd. Capital One Financial analyst P. Johnston now anticipates that the company will post earnings of $1.32 per share for the quarter, up from their prior estimate […]
- Related Articles
- In News
- From The Cerbat Gem
- 2024-04-10T01:26:43.000Z

In related news

Sage Therapeutics, Inc. (NASDAQ:SAGE) to Post Q1 2024 Earnings of ($1.64) Per Share, Leerink Partnrs Forecasts

Stoke Therapeutics, Inc. (NASDAQ:STOK) to Post Q2 2024 Earnings of ($0.43) Per Share, Leerink Partnrs Forecasts

Ovintiv Inc. to Post Q1 2024 Earnings of $1.32 Per Share, Capital One Financial Forecasts (NYSE:OVV)